body{display:block;}

Welcome to Berlin-Chemie Online Academy

This page contains information intended only for Healthcare Professionals.

Are you a Healthcare Professional?

Yes, I am a Healthcare Professional

UPCOMING LIVE WEBINARS

ON-DEMAND WEBINARS

  • COVID-19 impact on the management of multimorbid patients | Session 1

    16th May 2020 | 1:00 - 3:00 pm CEST

    COVID-19 impact on the management of multimorbid patients | Session 1

    • Cardio:
      Prof. R. Kreutz (Germany)
      Charité University Medicine Berlin, President of the European Society of Hypertension
      COVID-19 impact on the management of CVD patients
    • Respiratory:
      Prof. C. Vogelmeier (Germany)
      Director of the Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg
      COVID-19 and COPD patients – German experience
  • COVID-19 impact on the management of multimorbid patients | Session 2

    16th May 2020 | 1:00 - 3:00 pm CEST

    COVID-19 impact on the management of multimorbid patients | Session 2

    • Diabetes:
      Prof. A. Ceriello (Italy)
      Head of Diabetes Research Department, IRCCS MultiMedica, Milan
      Diabetes management during COVID-19
    • Pain:
      Prof. G. Varrassi (Italy)
      President of the World Institute of Pain
      Pain management during COVID-19 pandemic
  • Cardio Update

    03rd Jul 2019

    ESC / ESH Guidelines for the management of arterial hypertension. A patient centric approach.

    • Prof. A. Coca (Spain): Combination Treatment: which drugs for which patients?
    • Prof. A. Manolis (Greece): Are all antihypertensive drugs the same?
    • Prof. R. Kreutz (Germany): Hypertensive patients with comorbidities
    • Q&A interactive session
  • Hyperuricaemia Update

    03rd Jul 2019

    Hyperuricaemia in the scope of international guidelines and daily practice.

    • Prof. C. Borghi (Italy): Update on uric acid in new ESC / ESH Guidelines for the management of arterial hypertension
    • Prof. J. Kielstein (Germany): Hyperuricaemia in CKD Patients – when and how should we start to treat?
    • Q&A interactive session
  • Type II Diabetes Update

    04th Jul 2019

    Type II diabetes in two scopes of treatment.

    • Prof. A. Ceriello (Italy): Metformin in Type II Diabetes: choice with benefits
    • Prof. E. Standl (Germany): Role of DPP4 inhibitors in Type II Diabetes treatment
    • Q&A interactive session
  • Urology Update

    04th Jul 2019

    BPH and the treatment of related symptoms.

    • Prof. C. Gratzke (Germany): BPH symptoms and their medical treatment described in the EAU guidelines
    • Prof. A. Vinarov (Russia): Serenoa Repens – a treatment option for BPH symptoms
    • Q&A interactive session